BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28699480)

  • 1. Adulteration Practices of Psychoactive Illicit Drugs: An Updated Review.
    Solimini R; Rotolo MC; Pellegrini M; Minutillo A; Pacifici R; Busardò FP; Zaami S
    Curr Pharm Biotechnol; 2017; 18(7):524-530. PubMed ID: 28699480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cutting of cocaine and heroin: A critical review.
    Broséus J; Gentile N; Esseiva P
    Forensic Sci Int; 2016 May; 262():73-83. PubMed ID: 26974713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Texture of Psychoactive Illicit Drugs in Iran: Adulteration with Lead and other Active Pharmaceutical Ingredients.
    Akhgari M; Moradi F; Ziarati P
    J Psychoactive Drugs; 2018; 50(5):451-459. PubMed ID: 30130472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances.
    Di Trana A; Berardinelli D; Montanari E; Berretta P; Basile G; Huestis MA; Busardò FP
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adulterants in illicit drugs: a review of empirical evidence.
    Cole C; Jones L; McVeigh J; Kicman A; Syed Q; Bellis M
    Drug Test Anal; 2011 Feb; 3(2):89-96. PubMed ID: 21322119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The health threat of drugs of abuse adulteration by new psychoactive substances.
    Minutillo A; Palmi I; Mastrobattista L
    Clin Ter; 2019; 170(6):e425-e426. PubMed ID: 31696904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recreational drugs: the complication's pleasure?].
    Joye F; Donzé N; Frochaux V; Niquille M; Selz Amaudruz F
    Rev Med Suisse; 2013 Aug; 9(394):1454-60. PubMed ID: 24024389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-drug cocktails: Impurities in commonly used illicit drugs seized by police in Queensland, Australia.
    Peck Y; Clough AR; Culshaw PN; Liddell MJ
    Drug Alcohol Depend; 2019 Aug; 201():49-57. PubMed ID: 31181437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When does the cutting of cocaine and heroin occur? The first large-scale study based on the chemical analysis of cocaine and heroin seizures in Switzerland.
    Morelato M; Franscella D; Esseiva P; Broséus J
    Int J Drug Policy; 2019 Nov; 73():7-15. PubMed ID: 31330276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the risks associated with the use of new psychoactive substances (NPS): high variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products.
    Zamengo L; Frison G; Bettin C; Sciarrone R
    Toxicol Lett; 2014 Aug; 229(1):220-8. PubMed ID: 24910986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative, quantitative and temporal study of cutting agents for cocaine and heroin over 9 years.
    Broséus J; Gentile N; Bonadio Pont F; Garcia Gongora JM; Gasté L; Esseiva P
    Forensic Sci Int; 2015 Dec; 257():307-313. PubMed ID: 26448535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
    Giné CV; Espinosa IF; Vilamala MV
    Drug Test Anal; 2014; 6(7-8):819-24. PubMed ID: 24470121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005-2010.
    Schneider S; Meys F
    Forensic Sci Int; 2011 Oct; 212(1-3):242-6. PubMed ID: 21767923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
    Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
    BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
    Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
    Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typology of new psychoactive substance use among the general Australian population.
    Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R
    Drug Alcohol Depend; 2018 Jul; 188():126-134. PubMed ID: 29775956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the results of a drug sample analysis.
    Gomez J; Rodriguez A
    Bull Narc; 1989; 41(1-2):121-6. PubMed ID: 2765719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.
    Helander A; Bäckberg M
    Clin Toxicol (Phila); 2017 Jan; 55(1):1-3. PubMed ID: 27549399
    [No Abstract]   [Full Text] [Related]  

  • 20. Chromatography as Method for Analytical Confirmation of Paracetamol in Postmortem Material Together with Psychoactive Substances.
    Biscevic-Tokic J; Tokic N; Ibrahimpasic E
    Acta Inform Med; 2015 Oct; 23(5):322-5. PubMed ID: 26635443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.